1. Activation of mGlu2/3 receptors, a novel therapeutic approach to alleviate dyskinesia and psychosis in experimental parkinsonism. (1st November 2019) Authors: Frouni, Imane; Hamadjida, Adjia; Kwan, Cynthia; Bédard, Dominique; Nafade, Vaidehi; Gaudette, Fleur; Nuara, Stephen G.; Gourdon, Jim C.; Beaudry, Francis; Huot, Philippe Journal: Neuropharmacology Issue: Volume 158(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Assessment of tandem mass spectrometry and high‐resolution mass spectrometry for the analysis of bupivacaine in plasma. (12th May 2015) Authors: Gaudette, Fleur; Benito, Javier; Steagall, Paulo; Beaudry, Francis Journal: Biomedical chromatography Issue: Volume 29:Number 11(2015:Nov.) Page Start: 1724 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Development and validation of probe drug cocktails for the characterization of CYP450-mediated metabolism by human heart microsomes. (1st February 2019) Authors: Huguet, Jade; Gaudette, Fleur; Michaud, Veronique; Turgeon, Jacques Journal: Xenobiotica Issue: Volume 49:Number 2(2019:Feb.) Page Start: 187 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Quantitative determination of LY‐404, 039, a metabotropic glutamate 2/3 receptor agonist, in rat plasma using chemical derivatization and HPLC–MRM/MS. (21st June 2022) Authors: Kang, Woojin; Gaudette, Fleur; Bédard, Dominique; Beaudry, Francis; Huot, Philippe Journal: Biomedical chromatography Issue: Volume 36:Number 9(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Selective blockade of the 5-HT3 receptor acutely alleviates dyskinesia and psychosis in the parkinsonian marmoset. (January 2021) Authors: Kwan, Cynthia; Nuara, Stephen G.; Bédard, Dominique; Gaudette, Fleur; Gourdon, Jim C.; Beaudry, Francis; Huot, Philippe Journal: Neuropharmacology Issue: Volume 182(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. The highly selective 5-HT2A antagonist EMD-281, 014 reduces dyskinesia and psychosis in the l-DOPA-treated parkinsonian marmoset. (1st September 2018) Authors: Hamadjida, Adjia; Nuara, Stephen G.; Bédard, Dominique; Gaudette, Fleur; Beaudry, Francis; Gourdon, Jim C.; Huot, Philippe Journal: Neuropharmacology Issue: Volume 139(2018) Page Start: 61 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Use of 4β‐Hydroxycholesterol Plasma Concentrations as an Endogenous Biomarker of CYP3A Activity: Clinical Validation in Individuals With Type 2 Diabetes. Issue 4 (5th June 2019) Authors: Gravel, Sophie; Chiasson, Jean‐Louis; Gaudette, Fleur; Turgeon, Jacques; Michaud, Veronique Journal: Clinical pharmacology & therapeutics Issue: Volume 106:Issue 4(2019) Page Start: 831 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗